Showing 9 of 9 recruiting trials for “Lymphangioleiomyomatosis”
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
The Genotype and Phenotype of Lymphangioleiomyomatosis
Enrolling by InvitationNCT05727852 ↗
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
RecruitingNCT03193892 ↗
A National Registry on Chinese Patients With Lymphangioleiomyomatosis
RecruitingNCT05676099 ↗
TSC Biosample Repository and Natural History Database
RecruitingNCT02432560 ↗
Safety and Durability of Sirolimus for Treatment of LAM
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
👨⚕️ Joel Moss, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Jun 2013View details ↗
RecruitingNCT01484236 ↗
National Lymphangioleiomyomatosis Registry, France
👨⚕️ Vincent Cottin, MD, Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires, HCL📍 1 site📅 Started Jan 2012View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →